Myasthenia gravis is a rare autoimmune neuromuscular disorder marked by fluctuating muscle weakness due to impaired communication between nerves and muscles. Most cases involve autoantibodies against Acetylcholine Receptors (AChRs), reducing their numbers, blocking function, or disrupting alignment, leading to diminished muscle responsiveness. Symptoms often begin with ocular issues, drooping eyelids, or double vision, with many progressing to generalized myasthenia gravis (gMG) affecting facial, limb, neck, or swallowing muscles. Severe cases can compromise breathing, causing a myasthenic crisis requiring urgent intervention. Emerging biologics and complement inhibit...
